FDA committee to review OTC decongestants Drug makers send letters to FDA over Cobalt's generic Altace King announces accelerated plan; will cut workforce by 20% CHPA issues warning regarding overreaction in FDA assessment of pediatric cough-cold medicines Report finds U.S. behind E.U. in biosimilar approvals Many angered by House's inability to override SCHIP veto FTC sends warning to lens companies selling without a prescription FDA approves label change to reflect potential hearing loss from E.D. drugs Report calls into question marketing of OTC cold medicines for children BIO asks Congress to restore SBIR grant eligibility First Previous 643 644 645 646 647 Next Last
